Capital Investment Advisory Services’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,600
Closed -$44.8K 1186
2025
Q3
$44.8K Sell
10,600
-17,800
-63% -$78.2K ﹤0.01% 791
2025
Q2
$141K Sell
28,400
-1,265
-4% -$5.5K 0.01% 602
2025
Q1
$131K Buy
29,665
+300
+1% +$1.41K 0.01% 581
2024
Q4
$137K Sell
29,365
-2,400
-8% -$13.2K 0.01% 524
2024
Q3
$220K Sell
31,765
-700
-2% -$5.49K 0.02% 474
2024
Q2
$253K Buy
+32,465
New +$240K 0.03% 436
2022
Q3
Sell
-10,140
Closed -$60K 827
2022
Q2
$60K Sell
10,140
-100
-1% -$1.11K 0.01% 579
2022
Q1
$198K Sell
10,240
-15
-0.1% -$344 0.02% 494
2021
Q4
$335K Buy
10,255
+550
+6% +$22.1K 0.04% 350
2021
Q3
$398K Buy
+9,705
New +$352K 0.05% 304

Other funds holding GDRX

Capital Investment Advisory Services's GDRX Position: Q4 2025 in Review

Capital Investment Advisory Services sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 10,600 shares — an estimated $44.8K sold.

Capital Investment Advisory Services first reported a position in GDRX in Q3 2021 and held it in 10 quarters. The position peaked at $398K in Q3 2021. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • Capital Investment Advisory Services reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
  • Capital Investment Advisory Services sold 10,600 GoodRx Holdings shares in Q4 2025, an estimated $44.8K.
  • Capital Investment Advisory Services first reported a position in GoodRx Holdings in Q3 2021 and held it in 10 quarters.
  • Capital Investment Advisory Services's GoodRx Holdings position peaked at $398K in Q3 2021.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Capital Investment Advisory Services's 13F filing for Q4 2025, filed 21 Jan 2026.